Year: 2020

Vaccitech receives government grant for COVID-19 vaccine research

Oxford, UK - Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces today that it has received a non-dilutive Government grant to support research with its next-generation...

Vacancy: Senior Scientist – Process Development

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for a Senior Scientist - Process Development, which is an office and laboratory-based role in the UK. Please see the role...

Oxford COVID-19 vaccine begins human trial stage

Oxford, UK - Vaccitech announces today that its scientific founders at the Jenner Institute, University of Oxford, have begun testing a COVID-19 vaccine in human volunteers. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half...

Vaccitech to Present at Solebury Trout Virtual Investor Conference

Oxford, UK – 30th March 2020  Vaccitech Ltd, a clinical stage biopharmaceutical company developing immunotherapies to treat infectious diseases and cancer, announced today that its Chief Executive Officer, Bill Enright, will present an update on the Company’s progress...

Vacancy: Clinical Programme Lead

To assist with the coordination and oversight of cross-functional activities to support the Vaccitech portfolio of research and development programmes. All activities carried out within allocated time, and agreed costs in accordance with quality requirements,...